English Overview
In this lecture, Prof. Maria Chimenti will discus the latest real world evidence on the use of IL-17 and JAK inhibitors from many different aspects including safety, efficacy and overall benefit to the patients.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
1. To review the latest Real-World-Evidence and personal experience on the use of JAK inhibitors in Rheumatoid Arthritis and IL-17 inhibitors in Psoriatic Arthritis in a real world setting.
2. To discuss the predictors of response and long term efficacy and safety of IL-17 and JAK inhibitors.
2. To discuss the predictors of response and long term efficacy and safety of IL-17 and JAK inhibitors.
Recorded Programs
Recording Part 1
Due Date 30/11/2021
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Real-World Use of IL-17 and JAK inhibitors in Rheumatology Certificate
Accreditation |
Certificate | Free |
VAT 15% Included
